下一个

自动播放

The future of CTCL therapy

2 意见 • 08/09/23
分享
嵌入
administrator
administrator
订户
0

Julia Jane Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham, Birmingham, UK, shares her views on the future of cutaneous T-cell lymphoma (CTCL) therapy, highlighting the unmet need for more efficacious therapies and to determine the optimal sequencing of therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放